Susanne Antonie Schaffert

General Manager Region Europe Oncology at Novartis Venture Fund

Susanne Antonie Schaffert

Susanne Antonie Schaffert

General Manager Region Europe Oncology at Novartis Venture Fund

Overview
Career Highlights

Advanced Accelerator Applications SA
Novartis Oncology, Inc.

RelSci Relationships

859

Number of Boards

4

Birthday

1967

Age

54

Contact Data
Trying to get in touch with Susanne Antonie Schaffert? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Susanne Antonie Schaffert likely has professional access to. A relationship does not necessarily indicate a personal connection.

Head of Strategic Venture Capital Fund, Pharma Equities at Novartis AG

Relationship likelihood: Strong

Chief Medical Officer at Novartis AG

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Chairman & President at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Group General Counsel of Novartis at Novartis AG

Relationship likelihood: Strong

Chief Digital Officer at Novartis AG

Relationship likelihood: Strong

Chief Executive Officer, Sandoz at Novartis AG

Relationship likelihood: Strong

Division Head, Alcon at Novartis AG

Relationship likelihood: Strong

President of Novartis Pharmaceuticals at Novartis AG

Relationship likelihood: Strong

Paths to Susanne Antonie Schaffert
Potential Connections via
Relationship Science
You
Susanne Antonie Schaffert
General Manager Region Europe Oncology at Novartis Venture Fund
Career History
Chief Executive Officer
2019 - Current

Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.

General Manager Region Europe Oncology
Current

NVF is an active venture capital investor focused on equity investments in Biotechnology/ Biopharma life sciences companies. It engages in seed investments as well as later-stage investments. It typically leads or co-leads an investment and plays an active role on company boards. The investment size is up to USD 30 million per company over its life. The investments are made in North America, Europe, Israel and in Asia/Pacific.

President of Novartis Oncology
Current

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Susanne Antonie Schaffert. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Susanne Antonie Schaffert's profile does not indicate a business or promotional relationship of any kind between RelSci and Susanne Antonie Schaffert.